Effectiveness of tildrakizumab 200 mg: an Italian multicenter study
<b>Conclusions:</b> Tildrakizumab 200 has been shown to be an effective therapeutic option, particularly for patients with high body weight, significant disease burden, and involvement of sensitive areas with no new safety signals.
Authors
- Giovanni Pellacani (ORCID: https://orcid.org/0000-0002-7222-2951)
- Diego Orsini (ORCID: https://orcid.org/0000-0002-3190-3988)
- Claudia Giofrè
- Francesco Loconsole (ORCID: https://orcid.org/0000-0003-2852-9451)
- Maria Esposito (ORCID: https://orcid.org/0000-0002-4773-6993)
- Annunziata Dattola (ORCID: https://orcid.org/0000-0001-9504-5882)
- Eugenia Veronica Di Brizzi (ORCID: https://orcid.org/0000-0002-0278-2443)
- Nicoletta Bernardini (ORCID: https://orcid.org/0000-0002-6295-3574)
- Antonio Giovanni Richetta
- Anna Balato (ORCID: https://orcid.org/0000-0001-5485-0172)
- Maria Concetta Fargnoli (ORCID: https://orcid.org/0000-0002-7249-2556)
- Concetta Potenza (ORCID: https://orcid.org/0000-0002-6300-8697)
- Gaia Moretta (ORCID: https://orcid.org/0000-0002-8839-5961)
- D D’Amico (ORCID: https://orcid.org/0000-0003-0766-8524)
- Giacomo Caldarola (ORCID: https://orcid.org/0000-0002-8837-9232)
- Clara De Simone (ORCID: https://orcid.org/0000-0002-0898-0045)
- Ketty Peris (ORCID: https://orcid.org/0000-0002-5237-0463)
- Viviana Lora (ORCID: https://orcid.org/0000-0002-3119-6224)
- Domenico Giordano (ORCID: https://orcid.org/0000-0003-0624-2097)
- Claudio Guarneri
- Severino Persechino (ORCID: https://orcid.org/0000-0002-3728-5877)
- Francesca Svara (ORCID: https://orcid.org/0009-0000-1723-4477)
- Simone Ragonesi
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Messina (IT)
- University of L'Aquila (IT)
- Agostino Gemelli University Polyclinic (IT)
- Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT)
- Istituto Dermopatico dell'Immacolata (IT)
- CTO Andrea Alesini (IT)
- San Gallicano Hospital (IT)
- Azienda Ospedaliera Pugliese Ciaccio (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte (IT)
- University of Naples Federico II (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2024-10-27
- DOI
- https://doi.org/10.1080/09546634.2024.2420825
- Citations
- 6
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.30